Existing user? Login

Dry eye

Neurostimulator device could provide non-pharmacological dry-eye relief

An intranasal neurostimulator device has been shown to significantly increase tear production in a one-day crossover study of 48 patients with dry eye.

Dry eye affects one in four people; however, those living with the condition have limited treatment options.

According to research presented at the American Academy of Ophthalmology Annual Meeting (12 November 2017), a team of researchers studied the efficacy of a neurostimulator device for increasing tear production in people with moderate-to-severe dry eye[1].

The team showed that, in a one-day crossover study with 48 patients, applying the device intranasally resulted in significantly greater tear production (25.3mm/min) compared with both a placebo device (9.2mm/min) and applying the device extranasally (9.5 mm/min).

The researchers followed 97 patients who used the device over 180 days, finding significantly greater tear production following neurostimulation than previously (17.3mm/min vs 7.9 mm/min).

No serious device-related adverse events were reported.

The team said the results indicated that the neurostimulation technology increased acute and long-term tear production in dry eye.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20204188

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Electronicjuice, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save

Supplementary images

  • Red, irritated eye

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.